Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing

J Natl Cancer Inst. 2001 Jan 3;93(1):2-4. doi: 10.1093/jnci/93.1.2.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Aged
  • Breast Neoplasms / prevention & control*
  • Cholesterol / blood
  • Coronary Disease / prevention & control*
  • Drug Administration Schedule
  • Estrogen Replacement Therapy* / methods
  • Estrogen Replacement Therapy* / standards
  • Estrogens, Non-Steroidal / pharmacology*
  • Estrogens, Non-Steroidal / therapeutic use
  • Female
  • Humans
  • Incidence
  • Medroxyprogesterone / pharmacology
  • Middle Aged
  • Osteoporosis, Postmenopausal / prevention & control*
  • Progesterone Congeners / pharmacology
  • Prospective Studies
  • Raloxifene Hydrochloride / pharmacology
  • Randomized Controlled Trials as Topic
  • Selective Estrogen Receptor Modulators / pharmacology*
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Tamoxifen / pharmacology

Substances

  • Estrogens, Non-Steroidal
  • Progesterone Congeners
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • Raloxifene Hydrochloride
  • Cholesterol
  • Medroxyprogesterone